Fair Value Calculator Fair Value Calculator
EN DE

MANJEERA (MANJEERA) Fair Value & Analysis

IN · Market cap ₹450M

M MANJEERA MANJEERA · BSE
Price₹36.00
Fair Value₹21.84
Upside-39.3%
Quality51/100
Watch MANJEERA for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹14.86 – ₹27.30

Fair value as of: Jul 5, 2026

From 22 valuation models · updated today

Price vs Fair Value (12 months)

₹36.00 ₹36.00 Fair Value ₹21.84 Jul 2025 Jul 2026

12‑month range ₹36.00 – ₹36.00 · fair‑value band ₹14.86 – ₹27.30 · the ₹36.00 price screens above the ₹21.84 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

MANJEERA (MANJEERA) currently trades at ₹36.00, while our model-based Fair Value estimate is ₹21.84 — implying the stock looks roughly 39.3% overvalued today. We read business quality at 51/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, MANJEERA generated revenue of ₹580M at a net margin of 39.7%. Revenue declined 7.5% year over year. Net debt stands at ₹2.9B. The stock trades on a trailing P/E of 2.0. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹14.86 (bear case) to ₹27.30 (bull case); at ₹36.00, the current price sits above that range. The share trades near its 52-week high, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹580M
Revenue growth (YoY) -7.5%
Net margin 39.7%
Free cash flow ₹54.1M FY2023
P/E ratio 2.0
Operating margin 44.8%
More key figures
EPS (TTM) ₹18.39
EPS growth (YoY) +89.9%
Net debt ₹2.9B FY2023

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2019 – FY2023 · reported fiscal years

MANJEERA reported revenue of ₹543M in FY2023 versus ₹2.3B in FY2019, a compound −30.7%/yr. Reported net income was ₹13.7M in FY2023.

Revenue −30.7%/yr
FY19 ₹2.3B
FY20 ₹635M
FY21 ₹980M
FY22 ₹872M
FY23 ₹543M
Net income
FY19 −₹455M
FY20 −₹510M
FY21 −₹424M
FY22 −₹485M
FY23 ₹13.7M

Is MANJEERA fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "MANJEERA Fair Value". https://www.fairvalue-calculator.com/stock/MANJEERA

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is MANJEERA (MANJEERA) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹21.84 versus a price of ₹36.00 — about −39% (overvalued). Model-based estimate, not financial advice.
What is the fair value of MANJEERA?
Our model-based fair value for MANJEERA is ₹21.84 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹36.00.
What is the quality score of MANJEERA?
MANJEERA has a Quality Score of 51/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of MANJEERA (MANJEERA)?
MANJEERA reported trailing-twelve-month revenue of about ₹580M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of MANJEERA?
The net profit margin of MANJEERA is about 39.7%, meaning it keeps roughly 39.7% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.